11 Alzheimers Disease Clinical Trials in Richmond, CA (2026)

Q: How do I join a clinical trial in Richmond?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Richmond research site will contact you.

Recruiting Alzheimers Disease Studies in Richmond

NCT05417594Recruiting

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

This study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AZD9574 individually and in combination with anti-cancer agents in participan...

Richmond, CA695 participantsAstraZeneca

View Study Details

NCT06818643Recruiting

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

Researchers are looking for new ways to treat people with certain advanced solid tumors. Advanced means the cancer has spread to other parts of the body and cannot be removed with surgery. Solid tumor...

Richmond, CA270 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07284290Recruiting

Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia

The proposed study aims to address the critical gaps in understanding the mechanisms of CF (Cognitive Fluctuations) by leveraging recently emerged molecular biomarkers, advanced neuroimaging technique...

Richmond, CA120 participantsVirginia Commonwealth University

View Study Details

NCT06028074Recruiting

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

GIM-122 is a first-in-class, humanized immunoglobulin G1 kappa dual functioning monoclonal antibody (DFA). This phase 1 / 2 study plans to evaluate the safety, tolerability, pharmacokinetics and clini...

Richmond, CA111 participantsGeorgiamune Inc

View Study Details

NCT03945162Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

This is a phase II, open-label, single-arm, multi-center Study conducted in Canada and the United States. Patients with NMIBC CIS (with or without resected papillary disease (Ta, T1)) that are conside...

Richmond, CA90 participantsTheralase® Technologies Inc.

View Study Details

NCT05962242Recruiting

HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma

The study will evaluate the safety and effectiveness of a lower than standard dose of radiation for definitive or adjuvant treatment of head and neck squamous cell carcinomas....

Richmond, CA90 participantsUniversity of Virginia

View Study Details

NCT05947279Recruiting

Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation

Motor adaptation and generalization are believed to occur via the integration of various forms of sensory feedback for a congruent representation of the body's position in space along with estimation ...

Richmond, CA60 participantsVirginia Commonwealth University

View Study Details

NCT06257693Recruiting

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

The study is to assess whether the Enolen is safe and delivers anti-androgen medication locally in patients that are planning for radical prostatectomy....

Richmond, CA56 participantsAlessa Therapeutics Inc.

View Study Details

NCT04789044Recruiting

Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)

The overall objective of this study is to determine the safety of PEG fusion when used with primary repair or reconstruction in patients with an acute upper extremity peripheral nerve injury. PEG is s...

Richmond, CA40 participantsMajor Extremity Trauma Research Consortium

View Study Details

NCT06874192Recruiting

Safety and Efficacy of LOw DOse COlchicine in Patients With STatin INTolerance: the LODOCO STINT Pilot Study

Statins are a class of cholesterol lowering medications that contribute to reducing a person's risk of experiencing a cardiovascular event like heart attack. Along with the ability to lower cholestero...

Richmond, CA30 participantsVirginia Commonwealth University

View Study Details

NCT06718686Recruiting

Rifaximin SSD in Dementia Trial

Using a new formulation of rifaximin, a non-absorbable antibiotic, to test if it can affect microbes in the gut of patients with dementia favorably....

Richmond, CA20 participantsJasmohan Bajaj

View Study Details

About Alzheimers Disease Clinical Trials in Richmond

Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.

There are currently 11 alzheimers disease clinical trials recruiting participants in Richmond, CA. These studies are seeking a combined 1,582 participants. Research is being sponsored by AstraZeneca, Merck Sharp & Dohme LLC, Virginia Commonwealth University and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Alzheimers Disease Clinical Trials in Richmond — FAQ

Are there alzheimers disease clinical trials in Richmond?

Yes, there are 11 alzheimers disease clinical trials currently recruiting in Richmond, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Richmond?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Richmond research site will contact you about next steps.

Are clinical trials in Richmond free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Richmond studies also compensate for your time and travel.

What alzheimers disease treatments are being tested?

The 11 active trials in Richmond are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.

Data updated July 13, 2026 from ClinicalTrials.gov